MedTrace Logo

Determine Return on Investment in Heart Failure Remote Monitoring Program

NCT02475577 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 163

Last updated 2016-03-31

No results posted yet for this study

Summary

The study will test a hypothesis that the remote monitoring with text and email alerts sent to study subject and optional family/other caregiver (Intervention 1) will have a higher return on investment compared to remote monitoring with nurse researcher follow-up telephone communication to study subject (on Blue alerts) or study subject's healthcare professional (on Red alerts) (Intervention 2) and self-monitoring without intervention (Control).

Conditions

Interventions

DEVICE

Peripherals with HealthInterlink technology

home remote monitoring

Sponsors & Collaborators

  • Welch Allyn

    collaborator INDUSTRY

  • NCH Healthcare System, Inc. dba Naples Comprehensive Health and dba NCH

    lead OTHER

Principal Investigators

  • Theresa Morrison, PhD · NCH Healthcare System Inc

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
89 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-06-30
Primary Completion
2017-06-30
Completion
2017-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02475577 on ClinicalTrials.gov